nodes	percent_of_prediction	percent_of_DWPC	metapath
Vandetanib—KDR—malaria	0.408	1	CbGaD
Vandetanib—FMO3—Dapsone—malaria	0.139	0.5	CbGbCtD
Vandetanib—ORM1—Quinidine—malaria	0.048	0.173	CbGbCtD
Vandetanib—CYP3A4—Clindamycin—malaria	0.0244	0.0875	CbGbCtD
Vandetanib—CYP3A4—Sulfadiazine—malaria	0.014	0.0503	CbGbCtD
Vandetanib—CYP3A4—Artemether—malaria	0.0119	0.0427	CbGbCtD
Vandetanib—CYP3A4—Proguanil—malaria	0.0112	0.0402	CbGbCtD
Vandetanib—CYP3A4—Doxycycline—malaria	0.0106	0.0381	CbGbCtD
Vandetanib—CYP3A4—Quinine—malaria	0.00721	0.0259	CbGbCtD
Vandetanib—CYP3A4—Quinidine—malaria	0.00633	0.0228	CbGbCtD
Vandetanib—CYP3A4—Dapsone—malaria	0.00546	0.0196	CbGbCtD
Vandetanib—LYN—blood plasma—malaria	0.00191	0.0185	CbGeAlD
Vandetanib—ORM1—saliva—malaria	0.00182	0.0176	CbGeAlD
Vandetanib—FLT4—endothelium—malaria	0.00167	0.0162	CbGeAlD
Vandetanib—RIPK2—endothelium—malaria	0.00166	0.0161	CbGeAlD
Vandetanib—FLT3—blood plasma—malaria	0.00163	0.0158	CbGeAlD
Vandetanib—BLK—hematopoietic system—malaria	0.00145	0.014	CbGeAlD
Vandetanib—PTK6—saliva-secreting gland—malaria	0.00144	0.0139	CbGeAlD
Vandetanib—PTK6—hematopoietic system—malaria	0.00137	0.0133	CbGeAlD
Vandetanib—TEK—endothelium—malaria	0.00134	0.013	CbGeAlD
Vandetanib—FYN—blood plasma—malaria	0.00122	0.0118	CbGeAlD
Vandetanib—SRC—endothelium—malaria	0.00119	0.0116	CbGeAlD
Vandetanib—PLK4—hematopoietic system—malaria	0.00113	0.011	CbGeAlD
Vandetanib—KDR—endothelium—malaria	0.0011	0.0106	CbGeAlD
Vandetanib—STK10—blood plasma—malaria	0.00109	0.0106	CbGeAlD
Vandetanib—TYRO3—hematopoietic system—malaria	0.00106	0.0103	CbGeAlD
Vandetanib—SRC—blood plasma—malaria	0.00106	0.0103	CbGeAlD
Vandetanib—LYN—hematopoietic system—malaria	0.00106	0.0102	CbGeAlD
Vandetanib—KDR—blood plasma—malaria	0.000975	0.00945	CbGeAlD
Vandetanib—BLK—blood—malaria	0.00096	0.0093	CbGeAlD
Vandetanib—PTK6—digestive system—malaria	0.000955	0.00926	CbGeAlD
Vandetanib—PTK6—blood—malaria	0.00091	0.00882	CbGeAlD
Vandetanib—FLT3—hematopoietic system—malaria	0.000903	0.00876	CbGeAlD
Vandetanib—RIPK2—saliva-secreting gland—malaria	0.000855	0.00829	CbGeAlD
Vandetanib—IRAK4—saliva-secreting gland—malaria	0.000835	0.00809	CbGeAlD
Vandetanib—FLT4—hematopoietic system—malaria	0.00082	0.00795	CbGeAlD
Vandetanib—ERBB3—saliva-secreting gland—malaria	0.000818	0.00793	CbGeAlD
Vandetanib—RIPK2—hematopoietic system—malaria	0.000816	0.00791	CbGeAlD
Vandetanib—IRAK4—hematopoietic system—malaria	0.000797	0.00772	CbGeAlD
Vandetanib—ERBB3—hematopoietic system—malaria	0.000781	0.00757	CbGeAlD
Vandetanib—PLK4—blood—malaria	0.000749	0.00726	CbGeAlD
Vandetanib—EPHA5—digestive system—malaria	0.000739	0.00716	CbGeAlD
Vandetanib—MKNK1—hematopoietic system—malaria	0.000733	0.00711	CbGeAlD
Vandetanib—SLK—saliva-secreting gland—malaria	0.000727	0.00705	CbGeAlD
Vandetanib—PLK4—bone marrow—malaria	0.000725	0.00703	CbGeAlD
Vandetanib—RET—hematopoietic system—malaria	0.000724	0.00702	CbGeAlD
Vandetanib—FGR—hematopoietic system—malaria	0.000724	0.00702	CbGeAlD
Vandetanib—AXL—hematopoietic system—malaria	0.000721	0.00699	CbGeAlD
Vandetanib—LYN—blood—malaria	0.0007	0.00679	CbGeAlD
Vandetanib—MAP4K5—saliva-secreting gland—malaria	0.000691	0.0067	CbGeAlD
Vandetanib—FYN—hematopoietic system—malaria	0.000675	0.00655	CbGeAlD
Vandetanib—FMO1—kidney—malaria	0.000663	0.00643	CbGeAlD
Vandetanib—EPHB6—saliva-secreting gland—malaria	0.000661	0.00641	CbGeAlD
Vandetanib—MAP4K5—hematopoietic system—malaria	0.00066	0.0064	CbGeAlD
Vandetanib—TEK—hematopoietic system—malaria	0.00066	0.0064	CbGeAlD
Vandetanib—ERBB3—kidney—malaria	0.00064	0.00621	CbGeAlD
Vandetanib—YES1—saliva-secreting gland—malaria	0.000638	0.00619	CbGeAlD
Vandetanib—YES1—hematopoietic system—malaria	0.000609	0.00591	CbGeAlD
Vandetanib—STK10—hematopoietic system—malaria	0.000604	0.00585	CbGeAlD
Vandetanib—FLT3—blood—malaria	0.000598	0.0058	CbGeAlD
Vandetanib—RET—kidney—malaria	0.000594	0.00576	CbGeAlD
Vandetanib—LTK—brain—malaria	0.000589	0.00571	CbGeAlD
Vandetanib—SRC—hematopoietic system—malaria	0.000586	0.00568	CbGeAlD
Vandetanib—FLT3—bone marrow—malaria	0.000579	0.00561	CbGeAlD
Vandetanib—ABL2—blood—malaria	0.000571	0.00554	CbGeAlD
Vandetanib—RIPK2—digestive system—malaria	0.000567	0.0055	CbGeAlD
Vandetanib—MAP2K5—saliva-secreting gland—malaria	0.000565	0.00548	CbGeAlD
Vandetanib—KDR—saliva-secreting gland—malaria	0.000565	0.00548	CbGeAlD
Vandetanib—EPHA8—brain—malaria	0.000564	0.00547	CbGeAlD
Vandetanib—FMO1—digestive system—malaria	0.000563	0.00546	CbGeAlD
Vandetanib—FYN—kidney—malaria	0.000553	0.00536	CbGeAlD
Vandetanib—LYN—liver—malaria	0.000547	0.00531	CbGeAlD
Vandetanib—FLT4—blood—malaria	0.000543	0.00527	CbGeAlD
Vandetanib—ERBB3—digestive system—malaria	0.000543	0.00526	CbGeAlD
Vandetanib—TEK—kidney—malaria	0.000541	0.00524	CbGeAlD
Vandetanib—RIPK2—blood—malaria	0.00054	0.00524	CbGeAlD
Vandetanib—KDR—hematopoietic system—malaria	0.000539	0.00523	CbGeAlD
Vandetanib—IRAK4—blood—malaria	0.000528	0.00512	CbGeAlD
Vandetanib—FLT4—bone marrow—malaria	0.000526	0.0051	CbGeAlD
Vandetanib—RIPK2—bone marrow—malaria	0.000523	0.00507	CbGeAlD
Vandetanib—VEGFA—bone marrow—malaria	0.000522	0.00506	CbGeAlD
Vandetanib—IRAK4—bone marrow—malaria	0.000511	0.00495	CbGeAlD
Vandetanib—MKNK1—digestive system—malaria	0.00051	0.00494	CbGeAlD
Vandetanib—FGR—digestive system—malaria	0.000504	0.00488	CbGeAlD
Vandetanib—RET—digestive system—malaria	0.000504	0.00488	CbGeAlD
Vandetanib—YES1—kidney—malaria	0.000499	0.00484	CbGeAlD
Vandetanib—STK10—kidney—malaria	0.000495	0.0048	CbGeAlD
Vandetanib—PDGFRB—saliva-secreting gland—malaria	0.000489	0.00474	CbGeAlD
Vandetanib—MKNK1—blood—malaria	0.000486	0.00471	CbGeAlD
Vandetanib—SRC—kidney—malaria	0.00048	0.00466	CbGeAlD
Vandetanib—FGR—blood—malaria	0.00048	0.00465	CbGeAlD
Vandetanib—LCK—blood—malaria	0.00048	0.00465	CbGeAlD
Vandetanib—RET—blood—malaria	0.00048	0.00465	CbGeAlD
Vandetanib—EPHA6—brain—malaria	0.000471	0.00456	CbGeAlD
Vandetanib—MKNK1—bone marrow—malaria	0.00047	0.00456	CbGeAlD
Vandetanib—FYN—digestive system—malaria	0.000469	0.00455	CbGeAlD
Vandetanib—FLT3—liver—malaria	0.000468	0.00454	CbGeAlD
Vandetanib—PDGFRB—hematopoietic system—malaria	0.000467	0.00452	CbGeAlD
Vandetanib—PLK4—brain—malaria	0.000465	0.00451	CbGeAlD
Vandetanib—FGR—bone marrow—malaria	0.000464	0.0045	CbGeAlD
Vandetanib—LCK—bone marrow—malaria	0.000464	0.0045	CbGeAlD
Vandetanib—SLK—blood—malaria	0.00046	0.00446	CbGeAlD
Vandetanib—STK35—liver—malaria	0.000458	0.00444	CbGeAlD
Vandetanib—FYN—blood—malaria	0.000447	0.00434	CbGeAlD
Vandetanib—ABL2—liver—malaria	0.000447	0.00433	CbGeAlD
Vandetanib—SLK—bone marrow—malaria	0.000445	0.00432	CbGeAlD
Vandetanib—KDR—kidney—malaria	0.000442	0.00428	CbGeAlD
Vandetanib—ORM1—hematopoietic system—malaria	0.000438	0.00424	CbGeAlD
Vandetanib—MAP4K5—blood—malaria	0.000437	0.00424	CbGeAlD
Vandetanib—TEK—blood—malaria	0.000437	0.00424	CbGeAlD
Vandetanib—EPHA5—brain—malaria	0.000437	0.00423	CbGeAlD
Vandetanib—TYRO3—brain—malaria	0.000437	0.00423	CbGeAlD
Vandetanib—EGFR—liver—malaria	0.000436	0.00423	CbGeAlD
Vandetanib—ABL1—saliva-secreting gland—malaria	0.000436	0.00423	CbGeAlD
Vandetanib—LYN—brain—malaria	0.000434	0.00421	CbGeAlD
Vandetanib—FYN—bone marrow—malaria	0.000433	0.0042	CbGeAlD
Vandetanib—Hypoglycaemia—Quinidine barbiturate—malaria	0.000433	0.00397	CcSEcCtD
Vandetanib—Lethargy—Quinidine barbiturate—malaria	0.000431	0.00396	CcSEcCtD
Vandetanib—BMPR1B—brain—malaria	0.000428	0.00415	CbGeAlD
Vandetanib—MAP3K19—brain—malaria	0.000428	0.00415	CbGeAlD
Vandetanib—Influenza—Dapsone—malaria	0.000426	0.00391	CcSEcCtD
Vandetanib—FLT4—liver—malaria	0.000425	0.00412	CbGeAlD
Vandetanib—YES1—digestive system—malaria	0.000424	0.00411	CbGeAlD
Vandetanib—MAP4K5—bone marrow—malaria	0.000423	0.0041	CbGeAlD
Vandetanib—RIPK2—liver—malaria	0.000423	0.0041	CbGeAlD
Vandetanib—VEGFA—liver—malaria	0.000421	0.00409	CbGeAlD
Vandetanib—STK10—digestive system—malaria	0.00042	0.00407	CbGeAlD
Vandetanib—FMO1—liver—malaria	0.000419	0.00406	CbGeAlD
Vandetanib—Erythema multiforme—Sulfadiazine—malaria	0.000419	0.00385	CcSEcCtD
Vandetanib—Pancreatitis—Dapsone—malaria	0.000418	0.00384	CcSEcCtD
Vandetanib—EPHB6—blood—malaria	0.000418	0.00405	CbGeAlD
Vandetanib—ABL1—hematopoietic system—malaria	0.000416	0.00403	CbGeAlD
Vandetanib—IRAK4—liver—malaria	0.000413	0.004	CbGeAlD
Vandetanib—Decreased appetite—Proguanil—malaria	0.000412	0.00378	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Proguanil—malaria	0.000409	0.00376	CcSEcCtD
Vandetanib—SRC—digestive system—malaria	0.000408	0.00395	CbGeAlD
Vandetanib—ERBB3—liver—malaria	0.000405	0.00392	CbGeAlD
Vandetanib—YES1—blood—malaria	0.000404	0.00391	CbGeAlD
Vandetanib—Cardiac arrest—Quinidine barbiturate—malaria	0.000401	0.00369	CcSEcCtD
Vandetanib—STK10—blood—malaria	0.0004	0.00388	CbGeAlD
Vandetanib—Bronchospasm—Quinine—malaria	0.000398	0.00365	CcSEcCtD
Vandetanib—Bronchospasm—Quinidine—malaria	0.000398	0.00365	CcSEcCtD
Vandetanib—YES1—bone marrow—malaria	0.000391	0.00379	CbGeAlD
Vandetanib—Photosensitivity reaction—Dapsone—malaria	0.000389	0.00357	CcSEcCtD
Vandetanib—SRC—blood—malaria	0.000388	0.00376	CbGeAlD
Vandetanib—Gastrointestinal pain—Proguanil—malaria	0.000388	0.00356	CcSEcCtD
Vandetanib—STK10—bone marrow—malaria	0.000387	0.00375	CbGeAlD
Vandetanib—Vomiting—Pyrimethamine—malaria	0.000387	0.00355	CcSEcCtD
Vandetanib—Neutropenia—Clindamycin—malaria	0.000385	0.00354	CcSEcCtD
Vandetanib—Dysuria—Clindamycin—malaria	0.000385	0.00354	CcSEcCtD
Vandetanib—Upper respiratory tract infection—Clindamycin—malaria	0.000383	0.00352	CcSEcCtD
Vandetanib—PDGFRB—kidney—malaria	0.000382	0.00371	CbGeAlD
Vandetanib—MKNK1—liver—malaria	0.00038	0.00368	CbGeAlD
Vandetanib—Neutropenia—Quinidine—malaria	0.000378	0.00347	CcSEcCtD
Vandetanib—Neutropenia—Quinine—malaria	0.000378	0.00347	CcSEcCtD
Vandetanib—Photosensitivity reaction—Clindamycin—malaria	0.000376	0.00345	CcSEcCtD
Vandetanib—FGR—liver—malaria	0.000375	0.00364	CbGeAlD
Vandetanib—LCK—liver—malaria	0.000375	0.00364	CbGeAlD
Vandetanib—KDR—digestive system—malaria	0.000375	0.00364	CbGeAlD
Vandetanib—Abdominal pain—Proguanil—malaria	0.000375	0.00344	CcSEcCtD
Vandetanib—Body temperature increased—Proguanil—malaria	0.000375	0.00344	CcSEcCtD
Vandetanib—AXL—liver—malaria	0.000374	0.00362	CbGeAlD
Vandetanib—Photosensitivity reaction—Quinine—malaria	0.000369	0.00339	CcSEcCtD
Vandetanib—Photosensitivity reaction—Quinidine—malaria	0.000369	0.00339	CcSEcCtD
Vandetanib—Stevens-Johnson syndrome—Clindamycin—malaria	0.000364	0.00335	CcSEcCtD
Vandetanib—STK35—brain—malaria	0.000364	0.00353	CbGeAlD
Vandetanib—FMO3—liver—malaria	0.000362	0.00351	CbGeAlD
Vandetanib—SLK—liver—malaria	0.00036	0.00349	CbGeAlD
Vandetanib—Bronchospasm—Quinidine barbiturate—malaria	0.000359	0.0033	CcSEcCtD
Vandetanib—Bronchospasm—Pentoxifylline—malaria	0.000358	0.00329	CcSEcCtD
Vandetanib—Stevens-Johnson syndrome—Quinine—malaria	0.000357	0.00328	CcSEcCtD
Vandetanib—Stevens-Johnson syndrome—Quinidine—malaria	0.000357	0.00328	CcSEcCtD
Vandetanib—KDR—blood—malaria	0.000357	0.00346	CbGeAlD
Vandetanib—MAP2K5—blood—malaria	0.000357	0.00346	CbGeAlD
Vandetanib—Urinary tract infection—Clindamycin—malaria	0.000357	0.00328	CcSEcCtD
Vandetanib—Sinusitis—Dapsone—malaria	0.000356	0.00327	CcSEcCtD
Vandetanib—ABL2—brain—malaria	0.000354	0.00344	CbGeAlD
Vandetanib—Renal failure—Quinidine—malaria	0.000354	0.00325	CcSEcCtD
Vandetanib—Renal failure—Quinine—malaria	0.000354	0.00325	CcSEcCtD
Vandetanib—FYN—liver—malaria	0.00035	0.00339	CbGeAlD
Vandetanib—Epistaxis—Clindamycin—malaria	0.000347	0.00318	CcSEcCtD
Vandetanib—EGFR—brain—malaria	0.000346	0.00335	CbGeAlD
Vandetanib—KDR—bone marrow—malaria	0.000346	0.00335	CbGeAlD
Vandetanib—TEK—liver—malaria	0.000342	0.00331	CbGeAlD
Vandetanib—MAP4K5—liver—malaria	0.000342	0.00331	CbGeAlD
Vandetanib—Neutropenia—Quinidine barbiturate—malaria	0.000341	0.00313	CcSEcCtD
Vandetanib—ABL1—kidney—malaria	0.000341	0.00331	CbGeAlD
Vandetanib—FLT4—brain—malaria	0.000337	0.00327	CbGeAlD
Vandetanib—RIPK2—brain—malaria	0.000335	0.00325	CbGeAlD
Vandetanib—VEGFA—brain—malaria	0.000334	0.00324	CbGeAlD
Vandetanib—Convulsion—Sulfadiazine—malaria	0.000334	0.00307	CcSEcCtD
Vandetanib—Photosensitivity reaction—Quinidine barbiturate—malaria	0.000333	0.00306	CcSEcCtD
Vandetanib—FMO1—brain—malaria	0.000333	0.00323	CbGeAlD
Vandetanib—CYP3A4—blood plasma—malaria	0.00033	0.0032	CbGeAlD
Vandetanib—Bradycardia—Quinine—malaria	0.000329	0.00303	CcSEcCtD
Vandetanib—Bradycardia—Quinidine—malaria	0.000329	0.00303	CcSEcCtD
Vandetanib—Arthralgia—Sulfadiazine—malaria	0.000328	0.00301	CcSEcCtD
Vandetanib—IRAK4—brain—malaria	0.000327	0.00318	CbGeAlD
Vandetanib—Haemoglobin—Quinidine—malaria	0.000325	0.00299	CcSEcCtD
Vandetanib—Haemoglobin—Quinine—malaria	0.000325	0.00299	CcSEcCtD
Vandetanib—Infestation—Pentoxifylline—malaria	0.000325	0.00298	CcSEcCtD
Vandetanib—Infestation NOS—Pentoxifylline—malaria	0.000325	0.00298	CcSEcCtD
Vandetanib—PDGFRB—digestive system—malaria	0.000325	0.00315	CbGeAlD
Vandetanib—Diarrhoea—Proguanil—malaria	0.000324	0.00298	CcSEcCtD
Vandetanib—Haemorrhage—Quinidine—malaria	0.000324	0.00297	CcSEcCtD
Vandetanib—Haemorrhage—Quinine—malaria	0.000324	0.00297	CcSEcCtD
Vandetanib—Stevens-Johnson syndrome—Quinidine barbiturate—malaria	0.000323	0.00296	CcSEcCtD
Vandetanib—ERBB3—brain—malaria	0.000321	0.00311	CbGeAlD
Vandetanib—Renal failure—Quinidine barbiturate—malaria	0.00032	0.00294	CcSEcCtD
Vandetanib—Urinary tract disorder—Quinine—malaria	0.00032	0.00293	CcSEcCtD
Vandetanib—Urinary tract disorder—Quinidine—malaria	0.00032	0.00293	CcSEcCtD
Vandetanib—Urethral disorder—Quinine—malaria	0.000317	0.00291	CcSEcCtD
Vandetanib—Urethral disorder—Quinidine—malaria	0.000317	0.00291	CcSEcCtD
Vandetanib—Conjunctivitis—Pentoxifylline—malaria	0.000316	0.0029	CcSEcCtD
Vandetanib—YES1—liver—malaria	0.000316	0.00306	CbGeAlD
Vandetanib—STK10—liver—malaria	0.000313	0.00303	CbGeAlD
Vandetanib—Erythema multiforme—Clindamycin—malaria	0.000312	0.00286	CcSEcCtD
Vandetanib—Visual impairment—Quinine—malaria	0.000312	0.00286	CcSEcCtD
Vandetanib—Visual impairment—Quinidine—malaria	0.000312	0.00286	CcSEcCtD
Vandetanib—PDGFRB—blood—malaria	0.000309	0.003	CbGeAlD
Vandetanib—Thrombocytopenia—Sulfadiazine—malaria	0.000308	0.00283	CcSEcCtD
Vandetanib—Hepatobiliary disease—Pentoxifylline—malaria	0.000307	0.00282	CcSEcCtD
Vandetanib—Epistaxis—Pentoxifylline—malaria	0.000306	0.00281	CcSEcCtD
Vandetanib—Erythema multiforme—Quinidine—malaria	0.000306	0.00281	CcSEcCtD
Vandetanib—Erythema multiforme—Quinine—malaria	0.000306	0.00281	CcSEcCtD
Vandetanib—SRC—liver—malaria	0.000304	0.00294	CbGeAlD
Vandetanib—Eye disorder—Quinidine—malaria	0.000302	0.00278	CcSEcCtD
Vandetanib—Eye disorder—Quinine—malaria	0.000302	0.00278	CcSEcCtD
Vandetanib—Vomiting—Proguanil—malaria	0.000301	0.00277	CcSEcCtD
Vandetanib—MKNK1—brain—malaria	0.000301	0.00292	CbGeAlD
Vandetanib—Cardiac disorder—Quinidine—malaria	0.0003	0.00276	CcSEcCtD
Vandetanib—Cardiac disorder—Quinine—malaria	0.0003	0.00276	CcSEcCtD
Vandetanib—PDGFRB—bone marrow—malaria	0.000299	0.0029	CbGeAlD
Vandetanib—Rash—Proguanil—malaria	0.000299	0.00275	CcSEcCtD
Vandetanib—Dermatitis—Proguanil—malaria	0.000299	0.00274	CcSEcCtD
Vandetanib—RET—brain—malaria	0.000298	0.00289	CbGeAlD
Vandetanib—FGR—brain—malaria	0.000298	0.00289	CbGeAlD
Vandetanib—Bradycardia—Quinidine barbiturate—malaria	0.000297	0.00273	CcSEcCtD
Vandetanib—Headache—Proguanil—malaria	0.000297	0.00273	CcSEcCtD
Vandetanib—AXL—brain—malaria	0.000296	0.00287	CbGeAlD
Vandetanib—Haemoglobin—Quinidine barbiturate—malaria	0.000294	0.0027	CcSEcCtD
Vandetanib—Haemoglobin—Pentoxifylline—malaria	0.000293	0.00269	CcSEcCtD
Vandetanib—Haemorrhage—Quinidine barbiturate—malaria	0.000292	0.00268	CcSEcCtD
Vandetanib—Mediastinal disorder—Quinine—malaria	0.000292	0.00268	CcSEcCtD
Vandetanib—Mediastinal disorder—Quinidine—malaria	0.000292	0.00268	CcSEcCtD
Vandetanib—Haemorrhage—Pentoxifylline—malaria	0.000292	0.00268	CcSEcCtD
Vandetanib—ORM1—blood—malaria	0.00029	0.00281	CbGeAlD
Vandetanib—ABL1—digestive system—malaria	0.000289	0.0028	CbGeAlD
Vandetanib—Urinary tract disorder—Quinidine barbiturate—malaria	0.000288	0.00265	CcSEcCtD
Vandetanib—FMO3—brain—malaria	0.000288	0.00279	CbGeAlD
Vandetanib—Musculoskeletal discomfort—Sulfadiazine—malaria	0.000287	0.00263	CcSEcCtD
Vandetanib—Urethral disorder—Quinidine barbiturate—malaria	0.000286	0.00263	CcSEcCtD
Vandetanib—SLK—brain—malaria	0.000285	0.00277	CbGeAlD
Vandetanib—Insomnia—Sulfadiazine—malaria	0.000285	0.00261	CcSEcCtD
Vandetanib—Mental disorder—Quinine—malaria	0.000284	0.0026	CcSEcCtD
Vandetanib—Mental disorder—Quinidine—malaria	0.000284	0.0026	CcSEcCtD
Vandetanib—Malnutrition—Quinine—malaria	0.000282	0.00259	CcSEcCtD
Vandetanib—Malnutrition—Quinidine—malaria	0.000282	0.00259	CcSEcCtD
Vandetanib—Nausea—Proguanil—malaria	0.000282	0.00259	CcSEcCtD
Vandetanib—Visual impairment—Quinidine barbiturate—malaria	0.000281	0.00258	CcSEcCtD
Vandetanib—Dysgeusia—Clindamycin—malaria	0.000281	0.00258	CcSEcCtD
Vandetanib—ORM1—bone marrow—malaria	0.000281	0.00272	CbGeAlD
Vandetanib—Vision blurred—Dapsone—malaria	0.00028	0.00257	CcSEcCtD
Vandetanib—KDR—liver—malaria	0.000279	0.00271	CbGeAlD
Vandetanib—MAP2K5—liver—malaria	0.000279	0.00271	CbGeAlD
Vandetanib—FYN—brain—malaria	0.000278	0.00269	CbGeAlD
Vandetanib—Erythema multiforme—Quinidine barbiturate—malaria	0.000276	0.00254	CcSEcCtD
Vandetanib—Muscle spasms—Clindamycin—malaria	0.000276	0.00254	CcSEcCtD
Vandetanib—ABL1—blood—malaria	0.000276	0.00267	CbGeAlD
Vandetanib—ABCG2—saliva-secreting gland—malaria	0.000275	0.00266	CbGeAlD
Vandetanib—Decreased appetite—Sulfadiazine—malaria	0.000274	0.00251	CcSEcCtD
Vandetanib—Eye disorder—Quinidine barbiturate—malaria	0.000273	0.00251	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Sulfadiazine—malaria	0.000272	0.0025	CcSEcCtD
Vandetanib—TEK—brain—malaria	0.000271	0.00263	CbGeAlD
Vandetanib—MAP4K5—brain—malaria	0.000271	0.00263	CbGeAlD
Vandetanib—Cardiac disorder—Quinidine barbiturate—malaria	0.000271	0.00249	CcSEcCtD
Vandetanib—ABL1—bone marrow—malaria	0.000267	0.00259	CbGeAlD
Vandetanib—Vision blurred—Quinidine—malaria	0.000265	0.00244	CcSEcCtD
Vandetanib—Vision blurred—Quinine—malaria	0.000265	0.00244	CcSEcCtD
Vandetanib—Tremor—Quinine—malaria	0.000264	0.00242	CcSEcCtD
Vandetanib—Tremor—Quinidine—malaria	0.000264	0.00242	CcSEcCtD
Vandetanib—Mediastinal disorder—Quinidine barbiturate—malaria	0.000263	0.00242	CcSEcCtD
Vandetanib—Arrhythmia—Pentoxifylline—malaria	0.00026	0.00239	CcSEcCtD
Vandetanib—EPHB6—brain—malaria	0.000259	0.00251	CbGeAlD
Vandetanib—Cough—Dapsone—malaria	0.000259	0.00238	CcSEcCtD
Vandetanib—Gastrointestinal pain—Sulfadiazine—malaria	0.000257	0.00236	CcSEcCtD
Vandetanib—Mental disorder—Quinidine barbiturate—malaria	0.000256	0.00235	CcSEcCtD
Vandetanib—Malnutrition—Quinidine barbiturate—malaria	0.000254	0.00233	CcSEcCtD
Vandetanib—YES1—brain—malaria	0.00025	0.00243	CbGeAlD
Vandetanib—Abdominal pain—Sulfadiazine—malaria	0.000249	0.00228	CcSEcCtD
Vandetanib—Body temperature increased—Sulfadiazine—malaria	0.000249	0.00228	CcSEcCtD
Vandetanib—Dysgeusia—Pentoxifylline—malaria	0.000249	0.00228	CcSEcCtD
Vandetanib—STK10—brain—malaria	0.000248	0.00241	CbGeAlD
Vandetanib—Hypertension—Clindamycin—malaria	0.000248	0.00228	CcSEcCtD
Vandetanib—Loss of consciousness—Quinidine—malaria	0.000248	0.00227	CcSEcCtD
Vandetanib—Loss of consciousness—Quinine—malaria	0.000248	0.00227	CcSEcCtD
Vandetanib—Convulsion—Quinine—malaria	0.000244	0.00224	CcSEcCtD
Vandetanib—Convulsion—Quinidine—malaria	0.000244	0.00224	CcSEcCtD
Vandetanib—Muscle spasms—Pentoxifylline—malaria	0.000244	0.00224	CcSEcCtD
Vandetanib—PDGFRB—liver—malaria	0.000242	0.00234	CbGeAlD
Vandetanib—SRC—brain—malaria	0.000241	0.00234	CbGeAlD
Vandetanib—Chest pain—Quinidine—malaria	0.00024	0.0022	CcSEcCtD
Vandetanib—Chest pain—Quinine—malaria	0.00024	0.0022	CcSEcCtD
Vandetanib—Vision blurred—Quinidine barbiturate—malaria	0.00024	0.0022	CcSEcCtD
Vandetanib—Vision blurred—Pentoxifylline—malaria	0.000239	0.0022	CcSEcCtD
Vandetanib—Tremor—Quinidine barbiturate—malaria	0.000238	0.00219	CcSEcCtD
Vandetanib—Unspecified disorder of skin and subcutaneous tissue—Quinine—malaria	0.000238	0.00219	CcSEcCtD
Vandetanib—Unspecified disorder of skin and subcutaneous tissue—Quinidine—malaria	0.000238	0.00219	CcSEcCtD
Vandetanib—Tremor—Pentoxifylline—malaria	0.000238	0.00218	CcSEcCtD
Vandetanib—Oedema—Quinidine—malaria	0.00023	0.00211	CcSEcCtD
Vandetanib—Oedema—Quinine—malaria	0.00023	0.00211	CcSEcCtD
Vandetanib—Thrombocytopenia—Clindamycin—malaria	0.000229	0.00211	CcSEcCtD
Vandetanib—ORM1—liver—malaria	0.000227	0.0022	CbGeAlD
Vandetanib—Nervous system disorder—Quinidine—malaria	0.000225	0.00207	CcSEcCtD
Vandetanib—Nervous system disorder—Quinine—malaria	0.000225	0.00207	CcSEcCtD
Vandetanib—Thrombocytopenia—Quinidine—malaria	0.000225	0.00207	CcSEcCtD
Vandetanib—Thrombocytopenia—Quinine—malaria	0.000225	0.00207	CcSEcCtD
Vandetanib—Loss of consciousness—Quinidine barbiturate—malaria	0.000223	0.00205	CcSEcCtD
Vandetanib—Skin disorder—Quinidine—malaria	0.000223	0.00205	CcSEcCtD
Vandetanib—Skin disorder—Quinine—malaria	0.000223	0.00205	CcSEcCtD
Vandetanib—Pruritus—Sulfadiazine—malaria	0.000223	0.00204	CcSEcCtD
Vandetanib—MAP2K5—brain—malaria	0.000222	0.00215	CbGeAlD
Vandetanib—KDR—brain—malaria	0.000222	0.00215	CbGeAlD
Vandetanib—Convulsion—Quinidine barbiturate—malaria	0.00022	0.00202	CcSEcCtD
Vandetanib—Convulsion—Pentoxifylline—malaria	0.00022	0.00202	CcSEcCtD
Vandetanib—Insomnia—Dapsone—malaria	0.000219	0.00201	CcSEcCtD
Vandetanib—Hypertension—Pentoxifylline—malaria	0.000219	0.00201	CcSEcCtD
Vandetanib—Chest pain—Quinidine barbiturate—malaria	0.000216	0.00199	CcSEcCtD
Vandetanib—Arthralgia—Quinidine barbiturate—malaria	0.000216	0.00199	CcSEcCtD
Vandetanib—Chest pain—Pentoxifylline—malaria	0.000216	0.00198	CcSEcCtD
Vandetanib—Anxiety—Quinidine barbiturate—malaria	0.000216	0.00198	CcSEcCtD
Vandetanib—ABL1—liver—malaria	0.000215	0.00209	CbGeAlD
Vandetanib—Diarrhoea—Sulfadiazine—malaria	0.000215	0.00198	CcSEcCtD
Vandetanib—Anxiety—Pentoxifylline—malaria	0.000215	0.00198	CcSEcCtD
Vandetanib—Unspecified disorder of skin and subcutaneous tissue—Quinidine barbiturate—malaria	0.000215	0.00197	CcSEcCtD
Vandetanib—Unspecified disorder of skin and subcutaneous tissue—Pentoxifylline—malaria	0.000215	0.00197	CcSEcCtD
Vandetanib—Dry mouth—Pentoxifylline—malaria	0.000211	0.00194	CcSEcCtD
Vandetanib—ABCC1—blood—malaria	0.00021	0.00204	CbGeAlD
Vandetanib—Musculoskeletal discomfort—Quinine—malaria	0.000209	0.00192	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Quinidine—malaria	0.000209	0.00192	CcSEcCtD
Vandetanib—Dyspnoea—Clindamycin—malaria	0.000209	0.00192	CcSEcCtD
Vandetanib—Oedema—Quinidine barbiturate—malaria	0.000207	0.00191	CcSEcCtD
Vandetanib—Oedema—Pentoxifylline—malaria	0.000207	0.0019	CcSEcCtD
Vandetanib—Dyspepsia—Clindamycin—malaria	0.000206	0.00189	CcSEcCtD
Vandetanib—Infection—Pentoxifylline—malaria	0.000206	0.00189	CcSEcCtD
Vandetanib—Dyspnoea—Quinidine—malaria	0.000205	0.00188	CcSEcCtD
Vandetanib—Dyspnoea—Quinine—malaria	0.000205	0.00188	CcSEcCtD
Vandetanib—Nervous system disorder—Quinidine barbiturate—malaria	0.000203	0.00187	CcSEcCtD
Vandetanib—Thrombocytopenia—Quinidine barbiturate—malaria	0.000203	0.00187	CcSEcCtD
Vandetanib—Thrombocytopenia—Pentoxifylline—malaria	0.000203	0.00186	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Clindamycin—malaria	0.000202	0.00186	CcSEcCtD
Vandetanib—Fatigue—Clindamycin—malaria	0.000202	0.00186	CcSEcCtD
Vandetanib—Skin disorder—Quinidine barbiturate—malaria	0.000202	0.00185	CcSEcCtD
Vandetanib—Skin disorder—Pentoxifylline—malaria	0.000201	0.00185	CcSEcCtD
Vandetanib—Pain—Clindamycin—malaria	0.0002	0.00184	CcSEcCtD
Vandetanib—Constipation—Clindamycin—malaria	0.0002	0.00184	CcSEcCtD
Vandetanib—Vomiting—Sulfadiazine—malaria	0.0002	0.00184	CcSEcCtD
Vandetanib—Decreased appetite—Quinidine—malaria	0.0002	0.00184	CcSEcCtD
Vandetanib—Decreased appetite—Quinine—malaria	0.0002	0.00184	CcSEcCtD
Vandetanib—ALB—liver—malaria	0.000199	0.00193	CbGeAlD
Vandetanib—Gastrointestinal disorder—Quinine—malaria	0.000198	0.00182	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Quinidine—malaria	0.000198	0.00182	CcSEcCtD
Vandetanib—Rash—Sulfadiazine—malaria	0.000198	0.00182	CcSEcCtD
Vandetanib—Dermatitis—Sulfadiazine—malaria	0.000198	0.00182	CcSEcCtD
Vandetanib—Gastrointestinal pain—Dapsone—malaria	0.000198	0.00182	CcSEcCtD
Vandetanib—Headache—Sulfadiazine—malaria	0.000197	0.00181	CcSEcCtD
Vandetanib—PDGFRB—brain—malaria	0.000192	0.00186	CbGeAlD
Vandetanib—Gastrointestinal pain—Clindamycin—malaria	0.000192	0.00176	CcSEcCtD
Vandetanib—Body temperature increased—Dapsone—malaria	0.000192	0.00176	CcSEcCtD
Vandetanib—Abdominal pain—Dapsone—malaria	0.000192	0.00176	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000189	0.00174	CcSEcCtD
Vandetanib—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000189	0.00173	CcSEcCtD
Vandetanib—Gastrointestinal pain—Quinine—malaria	0.000188	0.00173	CcSEcCtD
Vandetanib—Gastrointestinal pain—Quinidine—malaria	0.000188	0.00173	CcSEcCtD
Vandetanib—Insomnia—Pentoxifylline—malaria	0.000187	0.00172	CcSEcCtD
Vandetanib—Nausea—Sulfadiazine—malaria	0.000187	0.00172	CcSEcCtD
Vandetanib—Abdominal pain—Clindamycin—malaria	0.000185	0.0017	CcSEcCtD
Vandetanib—Body temperature increased—Clindamycin—malaria	0.000185	0.0017	CcSEcCtD
Vandetanib—Dyspnoea—Quinidine barbiturate—malaria	0.000185	0.0017	CcSEcCtD
Vandetanib—Dyspnoea—Pentoxifylline—malaria	0.000185	0.0017	CcSEcCtD
Vandetanib—CYP3A4—hematopoietic system—malaria	0.000183	0.00177	CbGeAlD
Vandetanib—Dyspepsia—Pentoxifylline—malaria	0.000182	0.00167	CcSEcCtD
Vandetanib—Abdominal pain—Quinine—malaria	0.000182	0.00167	CcSEcCtD
Vandetanib—Body temperature increased—Quinine—malaria	0.000182	0.00167	CcSEcCtD
Vandetanib—Abdominal pain—Quinidine—malaria	0.000182	0.00167	CcSEcCtD
Vandetanib—Body temperature increased—Quinidine—malaria	0.000182	0.00167	CcSEcCtD
Vandetanib—Decreased appetite—Quinidine barbiturate—malaria	0.00018	0.00166	CcSEcCtD
Vandetanib—Decreased appetite—Pentoxifylline—malaria	0.00018	0.00165	CcSEcCtD
Vandetanib—Gastrointestinal disorder—Quinidine barbiturate—malaria	0.000179	0.00165	CcSEcCtD
Vandetanib—Pain—Quinidine barbiturate—malaria	0.000177	0.00163	CcSEcCtD
Vandetanib—Constipation—Quinidine barbiturate—malaria	0.000177	0.00163	CcSEcCtD
Vandetanib—Constipation—Pentoxifylline—malaria	0.000177	0.00163	CcSEcCtD
Vandetanib—ABCG2—blood—malaria	0.000174	0.00168	CbGeAlD
Vandetanib—ABL1—brain—malaria	0.000171	0.00166	CbGeAlD
Vandetanib—Gastrointestinal pain—Quinidine barbiturate—malaria	0.00017	0.00156	CcSEcCtD
Vandetanib—Gastrointestinal pain—Pentoxifylline—malaria	0.000169	0.00156	CcSEcCtD
Vandetanib—Asthenia—Clindamycin—malaria	0.000168	0.00154	CcSEcCtD
Vandetanib—ABCG2—bone marrow—malaria	0.000168	0.00163	CbGeAlD
Vandetanib—Pruritus—Clindamycin—malaria	0.000166	0.00152	CcSEcCtD
Vandetanib—Asthenia—Quinidine—malaria	0.000165	0.00151	CcSEcCtD
Vandetanib—Asthenia—Quinine—malaria	0.000165	0.00151	CcSEcCtD
Vandetanib—ABCC1—liver—malaria	0.000164	0.00159	CbGeAlD
Vandetanib—Abdominal pain—Quinidine barbiturate—malaria	0.000164	0.00151	CcSEcCtD
Vandetanib—Body temperature increased—Quinidine barbiturate—malaria	0.000164	0.00151	CcSEcCtD
Vandetanib—Abdominal pain—Pentoxifylline—malaria	0.000164	0.0015	CcSEcCtD
Vandetanib—Body temperature increased—Pentoxifylline—malaria	0.000164	0.0015	CcSEcCtD
Vandetanib—Pruritus—Quinine—malaria	0.000163	0.00149	CcSEcCtD
Vandetanib—Pruritus—Quinidine—malaria	0.000163	0.00149	CcSEcCtD
Vandetanib—Diarrhoea—Clindamycin—malaria	0.00016	0.00147	CcSEcCtD
Vandetanib—ALB—brain—malaria	0.000158	0.00153	CbGeAlD
Vandetanib—Diarrhoea—Quinidine—malaria	0.000157	0.00144	CcSEcCtD
Vandetanib—Diarrhoea—Quinine—malaria	0.000157	0.00144	CcSEcCtD
Vandetanib—Dizziness—Clindamycin—malaria	0.000155	0.00142	CcSEcCtD
Vandetanib—Vomiting—Dapsone—malaria	0.000154	0.00141	CcSEcCtD
Vandetanib—Dizziness—Quinine—malaria	0.000152	0.0014	CcSEcCtD
Vandetanib—Dizziness—Quinidine—malaria	0.000152	0.0014	CcSEcCtD
Vandetanib—Headache—Dapsone—malaria	0.000152	0.00139	CcSEcCtD
Vandetanib—CYP3A4—kidney—malaria	0.00015	0.00145	CbGeAlD
Vandetanib—Vomiting—Clindamycin—malaria	0.000149	0.00137	CcSEcCtD
Vandetanib—Asthenia—Quinidine barbiturate—malaria	0.000149	0.00137	CcSEcCtD
Vandetanib—Asthenia—Pentoxifylline—malaria	0.000149	0.00136	CcSEcCtD
Vandetanib—Rash—Clindamycin—malaria	0.000148	0.00136	CcSEcCtD
Vandetanib—Dermatitis—Clindamycin—malaria	0.000148	0.00136	CcSEcCtD
Vandetanib—Headache—Clindamycin—malaria	0.000147	0.00135	CcSEcCtD
Vandetanib—Pruritus—Quinidine barbiturate—malaria	0.000147	0.00135	CcSEcCtD
Vandetanib—Pruritus—Pentoxifylline—malaria	0.000147	0.00135	CcSEcCtD
Vandetanib—Vomiting—Quinine—malaria	0.000146	0.00134	CcSEcCtD
Vandetanib—Vomiting—Quinidine—malaria	0.000146	0.00134	CcSEcCtD
Vandetanib—Rash—Quinidine—malaria	0.000145	0.00133	CcSEcCtD
Vandetanib—Rash—Quinine—malaria	0.000145	0.00133	CcSEcCtD
Vandetanib—Dermatitis—Quinine—malaria	0.000145	0.00133	CcSEcCtD
Vandetanib—Dermatitis—Quinidine—malaria	0.000145	0.00133	CcSEcCtD
Vandetanib—Headache—Quinidine—malaria	0.000144	0.00132	CcSEcCtD
Vandetanib—Headache—Quinine—malaria	0.000144	0.00132	CcSEcCtD
Vandetanib—Nausea—Dapsone—malaria	0.000144	0.00132	CcSEcCtD
Vandetanib—Diarrhoea—Quinidine barbiturate—malaria	0.000142	0.0013	CcSEcCtD
Vandetanib—Diarrhoea—Pentoxifylline—malaria	0.000142	0.0013	CcSEcCtD
Vandetanib—Nausea—Clindamycin—malaria	0.000139	0.00128	CcSEcCtD
Vandetanib—Dizziness—Quinidine barbiturate—malaria	0.000137	0.00126	CcSEcCtD
Vandetanib—Dizziness—Pentoxifylline—malaria	0.000137	0.00126	CcSEcCtD
Vandetanib—Nausea—Quinidine—malaria	0.000137	0.00125	CcSEcCtD
Vandetanib—Nausea—Quinine—malaria	0.000137	0.00125	CcSEcCtD
Vandetanib—ABCG2—liver—malaria	0.000136	0.00132	CbGeAlD
Vandetanib—Vomiting—Quinidine barbiturate—malaria	0.000132	0.00121	CcSEcCtD
Vandetanib—Vomiting—Pentoxifylline—malaria	0.000132	0.00121	CcSEcCtD
Vandetanib—Rash—Quinidine barbiturate—malaria	0.000131	0.0012	CcSEcCtD
Vandetanib—Dermatitis—Quinidine barbiturate—malaria	0.000131	0.0012	CcSEcCtD
Vandetanib—Rash—Pentoxifylline—malaria	0.000131	0.0012	CcSEcCtD
Vandetanib—Dermatitis—Pentoxifylline—malaria	0.00013	0.0012	CcSEcCtD
Vandetanib—ABCC1—brain—malaria	0.00013	0.00126	CbGeAlD
Vandetanib—Headache—Quinidine barbiturate—malaria	0.00013	0.00119	CcSEcCtD
Vandetanib—Headache—Pentoxifylline—malaria	0.00013	0.00119	CcSEcCtD
Vandetanib—CYP3A4—digestive system—malaria	0.000127	0.00123	CbGeAlD
Vandetanib—Nausea—Quinidine barbiturate—malaria	0.000123	0.00113	CcSEcCtD
Vandetanib—Nausea—Pentoxifylline—malaria	0.000123	0.00113	CcSEcCtD
Vandetanib—CYP3A4—blood—malaria	0.000121	0.00117	CbGeAlD
Vandetanib—ABCG2—brain—malaria	0.000108	0.00105	CbGeAlD
Vandetanib—CYP3A4—liver—malaria	9.47e-05	0.000918	CbGeAlD
Vandetanib—FYN—Hemostasis—IL2—malaria	1.13e-05	0.000111	CbGpPWpGaD
Vandetanib—BLK—Immune System—IFNG—malaria	1.13e-05	0.000111	CbGpPWpGaD
Vandetanib—FGR—Immune System—IFNG—malaria	1.12e-05	0.000111	CbGpPWpGaD
Vandetanib—SRC—Signaling by EGFR—IL6—malaria	1.12e-05	0.000111	CbGpPWpGaD
Vandetanib—LYN—Innate Immune System—CD4—malaria	1.12e-05	0.000111	CbGpPWpGaD
Vandetanib—FYN—Immune System—CD8A—malaria	1.12e-05	0.00011	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—HLA-B—malaria	1.12e-05	0.00011	CbGpPWpGaD
Vandetanib—ABL1—Innate Immune System—CD4—malaria	1.11e-05	0.00011	CbGpPWpGaD
Vandetanib—SRC—Signaling by EGFR in Cancer—IL6—malaria	1.11e-05	0.00011	CbGpPWpGaD
Vandetanib—SRC—Signaling by PDGF—IL6—malaria	1.11e-05	0.000109	CbGpPWpGaD
Vandetanib—FYN—Innate Immune System—CD4—malaria	1.1e-05	0.000109	CbGpPWpGaD
Vandetanib—PDGFRB—Adaptive Immune System—CD4—malaria	1.1e-05	0.000109	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—CD36—malaria	1.09e-05	0.000108	CbGpPWpGaD
Vandetanib—LYN—Immune System—HLA-B—malaria	1.09e-05	0.000108	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TLR9—malaria	1.09e-05	0.000108	CbGpPWpGaD
Vandetanib—ALB—Platelet activation, signaling and aggregation—IL2—malaria	1.09e-05	0.000107	CbGpPWpGaD
Vandetanib—ABL1—Immune System—HLA-B—malaria	1.09e-05	0.000107	CbGpPWpGaD
Vandetanib—BLK—Immune System—CD4—malaria	1.09e-05	0.000107	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling by NGF—IL6—malaria	1.08e-05	0.000107	CbGpPWpGaD
Vandetanib—FGR—Immune System—CD4—malaria	1.08e-05	0.000107	CbGpPWpGaD
Vandetanib—LYN—Cytokine Signaling in Immune system—IL6—malaria	1.08e-05	0.000107	CbGpPWpGaD
Vandetanib—FYN—Immune System—HLA-B—malaria	1.08e-05	0.000106	CbGpPWpGaD
Vandetanib—LYN—Adaptive Immune System—CD4—malaria	1.08e-05	0.000106	CbGpPWpGaD
Vandetanib—LYN—Immune System—CD36—malaria	1.07e-05	0.000106	CbGpPWpGaD
Vandetanib—ABL1—Immune System—CD36—malaria	1.07e-05	0.000105	CbGpPWpGaD
Vandetanib—FYN—Cytokine Signaling in Immune system—IL6—malaria	1.06e-05	0.000105	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—ICAM1—malaria	1.06e-05	0.000105	CbGpPWpGaD
Vandetanib—KDR—Developmental Biology—IL6—malaria	1.06e-05	0.000105	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—DHFR—malaria	1.06e-05	0.000105	CbGpPWpGaD
Vandetanib—FYN—Adaptive Immune System—CD4—malaria	1.06e-05	0.000105	CbGpPWpGaD
Vandetanib—FYN—Immune System—CD36—malaria	1.05e-05	0.000104	CbGpPWpGaD
Vandetanib—RIPK2—Innate Immune System—IL6—malaria	1.05e-05	0.000104	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—SCARB1—malaria	1.05e-05	0.000104	CbGpPWpGaD
Vandetanib—FYN—Signaling by NGF—IL6—malaria	1.05e-05	0.000103	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—IL1B—malaria	1.04e-05	0.000103	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—IL2—malaria	1.04e-05	0.000103	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—KDR—malaria	1.04e-05	0.000102	CbGpPWpGaD
Vandetanib—ALB—Metabolism—PKLR—malaria	1.04e-05	0.000102	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—IFNG—malaria	1.03e-05	0.000102	CbGpPWpGaD
Vandetanib—FGR—Innate Immune System—IL6—malaria	1.01e-05	9.94e-05	CbGpPWpGaD
Vandetanib—BLK—Immune System—IL1B—malaria	1e-05	9.92e-05	CbGpPWpGaD
Vandetanib—SRC—NGF signalling via TRKA from the plasma membrane—IL6—malaria	1e-05	9.9e-05	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—CD36—malaria	1e-05	9.89e-05	CbGpPWpGaD
Vandetanib—FGR—Immune System—IL1B—malaria	1e-05	9.89e-05	CbGpPWpGaD
Vandetanib—BLK—Immune System—IL2—malaria	1e-05	9.88e-05	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—IL2—malaria	1e-05	9.88e-05	CbGpPWpGaD
Vandetanib—FGR—Immune System—IL2—malaria	9.97e-06	9.85e-05	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—CD4—malaria	9.96e-06	9.84e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—CRP—malaria	9.86e-06	9.74e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IL18—malaria	9.81e-06	9.69e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CD40LG—malaria	9.77e-06	9.65e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CD8A—malaria	9.66e-06	9.54e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—CRP—malaria	9.66e-06	9.54e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—CRP—malaria	9.61e-06	9.49e-05	CbGpPWpGaD
Vandetanib—LYN—Axon guidance—IL6—malaria	9.61e-06	9.49e-05	CbGpPWpGaD
Vandetanib—ABL1—Axon guidance—IL6—malaria	9.56e-06	9.45e-05	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—CD4—malaria	9.52e-06	9.41e-05	CbGpPWpGaD
Vandetanib—VEGFA—Developmental Biology—IL6—malaria	9.52e-06	9.41e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—CRP—malaria	9.51e-06	9.39e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—KDR—malaria	9.49e-06	9.37e-05	CbGpPWpGaD
Vandetanib—FYN—Axon guidance—IL6—malaria	9.46e-06	9.35e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—TLR4—malaria	9.46e-06	9.34e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—IL18—malaria	9.45e-06	9.34e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—CD40LG—malaria	9.41e-06	9.3e-05	CbGpPWpGaD
Vandetanib—LCK—Hemostasis—IL2—malaria	9.38e-06	9.27e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—CD8A—malaria	9.31e-06	9.2e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—HLA-B—malaria	9.29e-06	9.18e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—TLR4—malaria	9.26e-06	9.15e-05	CbGpPWpGaD
Vandetanib—ERBB3—Innate Immune System—IL6—malaria	9.25e-06	9.14e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—G6PD—malaria	9.23e-06	9.12e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—TLR4—malaria	9.21e-06	9.1e-05	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—IL1B—malaria	9.2e-06	9.09e-05	CbGpPWpGaD
Vandetanib—ERBB3—Disease—CD4—malaria	9.2e-06	9.09e-05	CbGpPWpGaD
Vandetanib—YES1—Developmental Biology—IL6—malaria	9.2e-06	9.09e-05	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—CD4—malaria	9.18e-06	9.07e-05	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—IL2—malaria	9.17e-06	9.06e-05	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—CD4—malaria	9.15e-06	9.04e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—KDR—malaria	9.14e-06	9.03e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—TLR4—malaria	9.11e-06	9e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—CD36—malaria	9.11e-06	9e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CD36—malaria	9.11e-06	9e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—ICAM1—malaria	9.06e-06	8.96e-05	CbGpPWpGaD
Vandetanib—YES1—Immune System—IFNG—malaria	9.06e-06	8.95e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling by NGF—IL6—malaria	9.03e-06	8.92e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—HLA-B—malaria	8.95e-06	8.85e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—ICAM1—malaria	8.88e-06	8.77e-05	CbGpPWpGaD
Vandetanib—LCK—Cytokine Signaling in Immune system—IL6—malaria	8.85e-06	8.75e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—ICAM1—malaria	8.83e-06	8.73e-05	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—CD4—malaria	8.81e-06	8.71e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—CD36—malaria	8.78e-06	8.67e-05	CbGpPWpGaD
Vandetanib—YES1—Immune System—CD4—malaria	8.75e-06	8.64e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—ICAM1—malaria	8.74e-06	8.63e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling by NGF—IL6—malaria	8.7e-06	8.6e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—DHODH—malaria	8.68e-06	8.57e-05	CbGpPWpGaD
Vandetanib—LYN—Developmental Biology—TNF—malaria	8.5e-06	8.39e-05	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—IL6—malaria	8.48e-06	8.38e-05	CbGpPWpGaD
Vandetanib—ABL1—Developmental Biology—TNF—malaria	8.46e-06	8.36e-05	CbGpPWpGaD
Vandetanib—MKNK1—Disease—IL6—malaria	8.4e-06	8.3e-05	CbGpPWpGaD
Vandetanib—FYN—Developmental Biology—TNF—malaria	8.37e-06	8.26e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—IL18—malaria	8.37e-06	8.26e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—CD40LG—malaria	8.33e-06	8.23e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—KDR—malaria	8.31e-06	8.21e-05	CbGpPWpGaD
Vandetanib—SRC—Hemostasis—IL2—malaria	8.3e-06	8.2e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—NOS2—malaria	8.3e-06	8.2e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—CD8A—malaria	8.24e-06	8.14e-05	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—NOS2—malaria	8.23e-06	8.13e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CRP—malaria	8.21e-06	8.11e-05	CbGpPWpGaD
Vandetanib—EGFR—Axon guidance—IL6—malaria	8.17e-06	8.07e-05	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—CD4—malaria	8.13e-06	8.03e-05	CbGpPWpGaD
Vandetanib—YES1—Innate Immune System—IL6—malaria	8.12e-06	8.02e-05	CbGpPWpGaD
Vandetanib—YES1—Immune System—IL1B—malaria	8.08e-06	7.98e-05	CbGpPWpGaD
Vandetanib—YES1—Immune System—IL2—malaria	8.05e-06	7.95e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—KDR—malaria	8.03e-06	7.93e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—NOS2—malaria	8e-06	7.91e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—HLA-B—malaria	7.93e-06	7.83e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—CRP—malaria	7.91e-06	7.82e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—TLR4—malaria	7.87e-06	7.78e-05	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—CD4—malaria	7.8e-06	7.71e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—CD36—malaria	7.77e-06	7.68e-05	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—IL6—malaria	7.76e-06	7.67e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling by NGF—IL6—malaria	7.7e-06	7.61e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—TLR4—malaria	7.59e-06	7.5e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—ICAM1—malaria	7.55e-06	7.46e-05	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—CD36—malaria	7.47e-06	7.38e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—SLC4A1—malaria	7.38e-06	7.29e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—NOS2—malaria	7.34e-06	7.25e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—ICAM1—malaria	7.27e-06	7.19e-05	CbGpPWpGaD
Vandetanib—EGFR—Developmental Biology—TNF—malaria	7.23e-06	7.14e-05	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—IL6—malaria	7.1e-06	7.01e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—HPGDS—malaria	7.04e-06	6.96e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—CRP—malaria	7.01e-06	6.92e-05	CbGpPWpGaD
Vandetanib—SRC—Axon guidance—IL6—malaria	6.97e-06	6.89e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—DECR1—malaria	6.94e-06	6.85e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—NOS2—malaria	6.91e-06	6.83e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—IFNG—malaria	6.9e-06	6.81e-05	CbGpPWpGaD
Vandetanib—LYN—Developmental Biology—IL6—malaria	6.86e-06	6.77e-05	CbGpPWpGaD
Vandetanib—ABL1—Developmental Biology—IL6—malaria	6.83e-06	6.74e-05	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—IL6—malaria	6.76e-06	6.68e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—IFNG—malaria	6.75e-06	6.67e-05	CbGpPWpGaD
Vandetanib—FYN—Developmental Biology—IL6—malaria	6.75e-06	6.67e-05	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—IL2—malaria	6.72e-06	6.64e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—IFNG—malaria	6.72e-06	6.64e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—TLR4—malaria	6.72e-06	6.64e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—NOS2—malaria	6.66e-06	6.58e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—CD4—malaria	6.66e-06	6.58e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—IFNG—malaria	6.65e-06	6.57e-05	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—CD36—malaria	6.58e-06	6.5e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—DHFR—malaria	6.53e-06	6.45e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—CD4—malaria	6.52e-06	6.44e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—CD4—malaria	6.49e-06	6.41e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—SCARB1—malaria	6.47e-06	6.39e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—ICAM1—malaria	6.44e-06	6.36e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—CD4—malaria	6.42e-06	6.34e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—HBB—malaria	6.27e-06	6.2e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Innate Immune System—IL6—malaria	6.19e-06	6.11e-05	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—TNF—malaria	6.17e-06	6.09e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—IL1B—malaria	6.15e-06	6.08e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—CD4—malaria	6.15e-06	6.08e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—IL2—malaria	6.15e-06	6.08e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—IL2—malaria	6.13e-06	6.06e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—KDR—malaria	6.11e-06	6.04e-05	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—IL6—malaria	6.11e-06	6.04e-05	CbGpPWpGaD
Vandetanib—LYN—Innate Immune System—IL6—malaria	6.06e-06	5.98e-05	CbGpPWpGaD
Vandetanib—ABL1—Innate Immune System—IL6—malaria	6.03e-06	5.96e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—IL1B—malaria	6.02e-06	5.95e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—IL2—malaria	6e-06	5.93e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—IL1B—malaria	6e-06	5.92e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—IL2—malaria	5.99e-06	5.92e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—KDR—malaria	5.99e-06	5.91e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—IL2—malaria	5.97e-06	5.9e-05	CbGpPWpGaD
Vandetanib—FYN—Innate Immune System—IL6—malaria	5.96e-06	5.89e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—IL1B—malaria	5.93e-06	5.86e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—CD4—malaria	5.93e-06	5.86e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—IL2—malaria	5.93e-06	5.86e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—IL2—malaria	5.91e-06	5.84e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—NOS2—malaria	5.9e-06	5.83e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—KDR—malaria	5.89e-06	5.82e-05	CbGpPWpGaD
Vandetanib—BLK—Immune System—IL6—malaria	5.88e-06	5.81e-05	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—IL6—malaria	5.88e-06	5.81e-05	CbGpPWpGaD
Vandetanib—FGR—Immune System—IL6—malaria	5.86e-06	5.79e-05	CbGpPWpGaD
Vandetanib—EGFR—Developmental Biology—IL6—malaria	5.83e-06	5.76e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IFNG—malaria	5.74e-06	5.67e-05	CbGpPWpGaD
Vandetanib—ALB—Hemostasis—IL2—malaria	5.61e-06	5.54e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—PKLR—malaria	5.59e-06	5.53e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—IL2—malaria	5.59e-06	5.52e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—CD4—malaria	5.55e-06	5.48e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—IFNG—malaria	5.54e-06	5.47e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—CD4—malaria	5.43e-06	5.37e-05	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—IL6—malaria	5.39e-06	5.32e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—IL2—malaria	5.39e-06	5.32e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—CD4—malaria	5.35e-06	5.28e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—IL2—malaria	5.2e-06	5.14e-05	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—IL6—malaria	5.15e-06	5.09e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IL1B—malaria	5.12e-06	5.06e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—CD4—malaria	5.12e-06	5.06e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IL2—malaria	5.1e-06	5.04e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—KDR—malaria	5.09e-06	5.03e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—G6PD—malaria	4.98e-06	4.92e-05	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—IL6—malaria	4.98e-06	4.92e-05	CbGpPWpGaD
Vandetanib—ERBB3—Disease—IL6—malaria	4.98e-06	4.92e-05	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—IL6—malaria	4.96e-06	4.9e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—IL1B—malaria	4.94e-06	4.88e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—CD4—malaria	4.94e-06	4.88e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—IL2—malaria	4.92e-06	4.86e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—KDR—malaria	4.91e-06	4.85e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—IFNG—malaria	4.9e-06	4.84e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—CD4—malaria	4.73e-06	4.68e-05	CbGpPWpGaD
Vandetanib—YES1—Immune System—IL6—malaria	4.73e-06	4.67e-05	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—IL6—malaria	4.39e-06	4.34e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—IL1B—malaria	4.37e-06	4.32e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—CD4—malaria	4.37e-06	4.32e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—IL2—malaria	4.35e-06	4.3e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—KDR—malaria	4.34e-06	4.29e-05	CbGpPWpGaD
Vandetanib—ALB—Metabolism—CD36—malaria	4.06e-06	4.01e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—IL2—malaria	3.96e-06	3.91e-05	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—IL6—malaria	3.95e-06	3.9e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—IL2—malaria	3.88e-06	3.83e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—IL2—malaria	3.82e-06	3.77e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—HPGDS—malaria	3.8e-06	3.76e-05	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—IL6—malaria	3.61e-06	3.57e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—IL6—malaria	3.6e-06	3.56e-05	CbGpPWpGaD
Vandetanib—LYN—Immune System—IL6—malaria	3.53e-06	3.48e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—DHFR—malaria	3.53e-06	3.48e-05	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—IL6—malaria	3.52e-06	3.48e-05	CbGpPWpGaD
Vandetanib—ABL1—Immune System—IL6—malaria	3.51e-06	3.47e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—SCARB1—malaria	3.49e-06	3.45e-05	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—IL6—malaria	3.48e-06	3.44e-05	CbGpPWpGaD
Vandetanib—FYN—Immune System—IL6—malaria	3.47e-06	3.43e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—IL6—malaria	3.33e-06	3.29e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—IL2—malaria	3.3e-06	3.26e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling by GPCR—IL6—malaria	3.28e-06	3.24e-05	CbGpPWpGaD
Vandetanib—FYN—Disease—IL6—malaria	3.21e-06	3.17e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—IL2—malaria	3.18e-06	3.14e-05	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—IL6—malaria	3.17e-06	3.13e-05	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—IL6—malaria	3.06e-06	3.02e-05	CbGpPWpGaD
Vandetanib—EGFR—Immune System—IL6—malaria	3e-06	2.96e-05	CbGpPWpGaD
Vandetanib—ABCC1—Disease—IL6—malaria	2.94e-06	2.9e-05	CbGpPWpGaD
Vandetanib—LCK—Immune System—IL6—malaria	2.89e-06	2.86e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—IL2—malaria	2.82e-06	2.78e-05	CbGpPWpGaD
Vandetanib—EGFR—Disease—IL6—malaria	2.77e-06	2.74e-05	CbGpPWpGaD
Vandetanib—LCK—Disease—IL6—malaria	2.67e-06	2.64e-05	CbGpPWpGaD
Vandetanib—SRC—Immune System—IL6—malaria	2.56e-06	2.53e-05	CbGpPWpGaD
Vandetanib—SRC—Disease—IL6—malaria	2.36e-06	2.33e-05	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—IL6—malaria	2.33e-06	2.3e-05	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—IL6—malaria	2.28e-06	2.25e-05	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—IL6—malaria	2.25e-06	2.22e-05	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CD36—malaria	2.19e-06	2.16e-05	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—IL6—malaria	1.94e-06	1.92e-05	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—IL6—malaria	1.87e-06	1.85e-05	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—IL6—malaria	1.65e-06	1.63e-05	CbGpPWpGaD
